Pablo de Renteria

Stock Analyst at Kepler Capital

(0.49)
# 4,281
Out of 4,662 analysts
355
Total ratings
42.9%
Success rate
-3%
Average return

Stocks Rated by Pablo de Renteria

bioMérieux S.A.
Jun 25, 2026
Maintained: Buy
Price Target: €85.00
Current: €73.10
Upside: +16.28%
DiaSorin S.p.A.
Jun 25, 2026
Maintained: Buy
Price Target: €76.00
Current: €73.54
Upside: +3.35%
Lonza Group AG
May 8, 2026
Maintained: Buy
Price Target: CHF 670.00
Current: CHF 579.20
Upside: +15.68%
Indra Sistemas, S.A.
May 6, 2026
Maintained: Buy
Price Target: €76.00
Current: €61.72
Upside: +23.14%
Laboratorios Farmaceuticos Rovi, S.A.
May 6, 2026
Maintained: Buy
Price Target: €90.00€83.00
Current: €59.70
Upside: +39.03%
Viscofan, S.A.
Apr 24, 2026
Maintained: Buy
Price Target: €74.00
Current: €56.60
Upside: +30.74%
Siegfried Holding AG
Apr 24, 2026
Maintained: Hold
Price Target: CHF 85.00
Current: CHF 78.55
Upside: +8.21%
Ebro Foods, S.A.
Feb 24, 2026
Maintained: Hold
Price Target: €18.10
Current: €18.18
Upside: -0.44%
Almirall, S.A.
Feb 23, 2026
Maintained: Buy
Price Target: €13.30€14.20
Current: €10.38
Upside: +36.80%
Fluidra, S.A.
Jul 31, 2025
Maintained: Sell
Price Target: €19.20
Current: €19.13
Upside: n/a
Maintained: Hold
Price Target: €4.30
Current: €3.21
Upside: n/a
Maintained: Buy
Price Target: €4.20
Current: €2.52
Upside: n/a
Maintained: Buy
Price Target: €5.00
Current: €2.55
Upside: n/a
Maintained: Buy
Price Target: $20
Current: $8.25
Upside: n/a
Initiated Coverage: Buy
Price Target: €17.50
Current: €10.08
Upside: n/a
Maintained: Buy
Price Target: 9,500p
Current: 12,050p
Upside: n/a
Maintained: Buy
Price Target: €99.00€105.00
Current: €78.56
Upside: n/a
Maintained: Buy
Price Target: €5.00€10.70
Current: €3.30
Upside: n/a
Downgraded: Hold
Price Target: €28.70€32.00
Current: €58.28
Upside: n/a
Maintained: Buy
Price Target: €2.35
Current: €0.65
Upside: n/a
Maintained: Hold
Price Target: €120.00
Current: €80.30
Upside: n/a